What's new

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion

Jun 20, 2025 - 12:25
 0
Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion
Read More

Tags:

Previous Article

Summary of opinion: Cabometyx, 19/06/2025 Positive

Next Article

Summary of opinion: Nubeqa, 19/06/2025 Positive

Related Posts

Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 18, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Rybrevant, amivantamab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0166/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 6, 2025  0

Orphan designation: human IgG1 monoclonal antibody against sortilin Treatment of frontotemporal dementia, 15/10/2021 Positive

Orphan designation: human IgG1 monoclonal antibody agai...

Jun 10, 2025  0